Brain metastases in lung cancer

Laurie E Gaspar1

  • 1University of Colorado Health Sciences Center, Department of Radiation Oncology, 1663 N. Ursula Street, Box F-706, Suite 1032, Aurora, CO 80010-0510, USA. laurie.gaspar@uchsc.edu

Insights

Brain metastases from lung cancer, including non-small cell lung cancer and small cell lung cancer, are a significant research focus. This review covers prognostic factors and current treatments like chemotherapy, surgery, and radiation therapy.

Area of Science:

  • Oncology
  • Neurology

Background:

  • Brain metastases are a common complication of lung cancer, particularly non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
  • The brain is a frequent site of disease progression, sometimes as the sole site of recurrence after treatment for advanced NSCLC.
  • Outcomes and treatment approaches for lung cancer brain metastases can differ from those originating from other primary tumor types.

Purpose of the Study:

  • To review prognostic factors for lung cancer brain metastases.
  • To summarize current treatment modalities including chemotherapy, surgery, and radiation therapy.

Main Methods:

  • Literature review of prognostic factors.
  • Overview of established treatment strategies for brain metastases in lung cancer patients.

Main Results:

  • Key prognostic indicators for brain metastases from lung cancer have been identified.
  • Current treatment options encompass chemotherapy, surgical intervention, and various radiation therapy techniques.

Conclusions:

  • Understanding prognostic factors is crucial for managing lung cancer brain metastases.
  • A multimodal treatment approach combining systemic therapy, surgery, and radiation is often employed.